Skip to main content

Test Price

2,800 AED

โœ… Home Collection Available

DMD Gene Duchenne Muscular Dystrophy Genetic Test in UAE | 2800 AED | DNA Labs UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).

Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all UAE emirates.

Clinical Guidance: Telephonic post-test clinical guidance with a DHA-licensed physician to interpret your results in English.

Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731. We coordinate directly with major UAE insurers.

Test Overview & Methodology

This Next-Generation Sequencing (NGS) test analyzes the entire DMD gene for deletions, duplications, and point mutations causing Duchenne Muscular Dystrophy (DMD)โ€”a devastating X-linked recessive neuromuscular disorder primarily affecting boys. Our methodology combines deep sequencing with advanced copy number variant (CNV) algorithms, delivering a diagnostic yield >99% for coding variants, outperforming traditional MLPA-only approaches that miss approximately 30% of point mutations.

Test Feature Our NGS + CNV Test (This Test) Standard MLPA (Alternative)
Detection Coverage Full gene sequencing + exon-level deletions/duplications Deletion/duplication screening only; misses ~30% of pathogenic point mutations
Turnaround Time 3โ€“4 Weeks 2โ€“4 Weeks
Diagnostic Sensitivity >99% for all variant types combined Approx. 70% for DMD
Sample Flexibility Whole blood in EDTA, extracted DNA, or one drop blood on FTA card Whole blood required

Physician Insight & Safety Protocols

Note from Dr. Lina Osama Zaki Quteineh (DHA Registration ID: 9294403, Consultant Medical Genetics): A DMD genetic result is life-altering and must be correlated with clinical presentation, creatine kinase levels, and family history. Even with a negative NGS result, dystrophinopathies or limb-girdle muscular dystrophies are not excluded; a muscle biopsy may still be indicated. Involving a genetic counselor and a pediatric neurologist is essential from the moment testing is considered.

Medication Advisory

๐Ÿšจ Medication Warning

Do not discontinue any prescribed medication, including corticosteroids or cardiac therapies, without consulting your physician. Corticosteroids can influence CPK levels and may mask clinical symptoms.

Safety Exclusion Criteria & Emergency Red Flags

๐Ÿšจ Exclusion Criteria

  • Not suitable for patients who received a bone marrow transplant or recent blood transfusion (within 14 days) due to donor DNA contamination.
  • If the child develops acute respiratory difficulty, severe muscle weakness with frequent falls, or cardiac symptoms (palpitations, chest pain, syncope), go to the nearest emergency department immediatelyโ€”do not await test results.
  • Prenatal DMD testing is allowed only after a genetic counseling session and mandatory informed consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
  • Test results must be disclosed by a qualified healthcare professional; direct-to-consumer reporting is not permitted.

Patient FAQ & Clinical Guidance

1. How accurate is this NGS test for diagnosing Duchenne Muscular Dystrophy in children?

Our ACMG-aligned NGS panel achieves 99.9% diagnostic sensitivity for all pathogenic DMD variants, covering single nucleotide variants, insertions/deletions, and large copy number changes.

2. Can I use a buccal swab or just a drop of blood on a card instead of a full blood draw?

Yes, we accept whole blood in EDTA, extracted DNA, or one dried blood spot on an FTA cardโ€”cold-chain logistics are maintained for all sample types during home collection.

3. How long do results take, and what support is provided after the test?

Turnaround time is 3โ€“4 weeks; you receive a telephonic post-test genetic counseling session with a certified counselor, and a comprehensive clinical report.

UAE Regulatory & Data Privacy Adherence

This service complies with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All sequencing data is stored securely on UAE-based servers with ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). Patient consent and safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. DHA Facility License Number: 1143.

Clinical & Logistical Metadata

Test Name DMD Gene Duchenne Muscular Dystrophy Genetic Test โ€“ NGS
Price (AED) 2,800 AED
Turnaround Time 3โ€“4 Weeks
Sample Type / Matrix Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card
Methodology Used Next-Generation Sequencing (NGS) with CNV analysis
ICD-10-CM Code G71.0 (Muscular dystrophy)
LOINC Code 51938-5 (DMD gene mutation analysis)
DHA Facility License & Address License No. 1143 โ€“ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ€“ DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians